Mucopolysaccharidosis III

Explore clinical trials studying Mucopolysaccharidosis III. Study availability and eligibility vary by location and protocol.

4 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Mucopolysaccharidosis III trial results

Recruiting

NCT02716246

Conditions: Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +12 more
Locations: Nationwide Children's Hospital Columbus, Ohio, United States

Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States

Women's and Children's Hospital North Adelaide, South Australia, Australia

Vall d'Hebron Barcelona Hospital Campus Barcelona, Spain

Recruiting

NCT06333041

Conditions: Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +10 more
Locations: The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Torrance, California, United States

Recruiting

NCT06036693

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +33 more
Locations: Centre Hospitalier Universitaire d'Angers Angers, France

Hôpital des Enfants - Groupe Hospitalier Pellegrin Bordeaux, France

Hôpital Morvan Brest, France

Hôpital d'Estaing Clermont-Ferrand, France

View all 23 locations

Completed

NCT04018755

Conditions: Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +9 more
Locations: The Lundquist Institute at Harbor-UCLA Medical Center Torrance, California, United States